FI954852A0 - 1,5-bentzodiazepine derivatives with CCK and / or gastrin antagonistic activity - Google Patents

1,5-bentzodiazepine derivatives with CCK and / or gastrin antagonistic activity

Info

Publication number
FI954852A0
FI954852A0 FI954852A FI954852A FI954852A0 FI 954852 A0 FI954852 A0 FI 954852A0 FI 954852 A FI954852 A FI 954852A FI 954852 A FI954852 A FI 954852A FI 954852 A0 FI954852 A0 FI 954852A0
Authority
FI
Finland
Prior art keywords
bentzodiazepine
cck
derivatives
antagonistic activity
gastrin
Prior art date
Application number
FI954852A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI954852A (en
Inventor
Harry Finch
Pritom Shah
Robin Arthur Ellis Carr
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939307833A external-priority patent/GB9307833D0/en
Priority claimed from GB9406037A external-priority patent/GB9406037D0/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of FI954852A0 publication Critical patent/FI954852A0/en
Publication of FI954852A publication Critical patent/FI954852A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI954852A 1993-04-15 1995-10-12 1,5-Benzodiazepine derivatives with CCK and / or gastrin antagonist activity FI954852A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939307833A GB9307833D0 (en) 1993-04-15 1993-04-15 Modulators of cholecystokinin and gastrin
GB9406037A GB9406037D0 (en) 1994-03-29 1994-03-29 1,5 Benzodiazepine derivatives
PCT/EP1994/001130 WO1994024151A1 (en) 1993-04-15 1994-04-13 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity

Publications (2)

Publication Number Publication Date
FI954852A0 true FI954852A0 (en) 1995-10-12
FI954852A FI954852A (en) 1995-10-12

Family

ID=26302765

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954852A FI954852A (en) 1993-04-15 1995-10-12 1,5-Benzodiazepine derivatives with CCK and / or gastrin antagonist activity

Country Status (14)

Country Link
EP (1) EP0694040A1 (en)
JP (1) JPH08508743A (en)
CN (1) CN1120845A (en)
AU (1) AU688316B2 (en)
CA (1) CA2158972A1 (en)
CZ (1) CZ267695A3 (en)
FI (1) FI954852A (en)
HU (1) HUT74091A (en)
NO (1) NO954091L (en)
NZ (1) NZ265271A (en)
OA (1) OA10236A (en)
PL (1) PL311083A1 (en)
SK (1) SK125495A3 (en)
WO (1) WO1994024151A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69430068T2 (en) * 1993-12-28 2002-08-14 Shionogi & Co benzodiazepine derivatives
US6239131B1 (en) * 1996-12-10 2001-05-29 Zeria Pharmaceutical Co., Ltd. 1,5 Benzodiazepine derivatives
US6444849B1 (en) 1997-06-25 2002-09-03 Mitsubishi Chemical Corporation Amide derivatives
JP2000026434A (en) 1998-06-05 2000-01-25 Zeria Pharmaceut Co Ltd New 1,5-benzodiazepine derivative
EP1142868A4 (en) * 1998-12-22 2004-09-29 Mitsubishi Chem Corp Amide derivatives
GB201414116D0 (en) 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives
GB201513979D0 (en) 2015-08-07 2015-09-23 Trio Medicines Ltd Synthesis of benzodiazepine derivatives
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (en) * 1988-12-29 1994-01-21 Roussel Uclaf NOVEL 2,4-DIOXO 2,3,4,5-TETRAHYDRO 1H-1,5-BENZODIAZEPINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE AS MEDICAMENTS
FR2659653B1 (en) * 1990-03-13 1992-05-22 Rhone Poulenc Sante DERIVATIVES OF UREA, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
OA10236A (en) 1997-10-07
NZ265271A (en) 1997-06-24
AU6567594A (en) 1994-11-08
SK125495A3 (en) 1996-06-05
CA2158972A1 (en) 1994-10-27
NO954091D0 (en) 1995-10-13
CZ267695A3 (en) 1996-04-17
WO1994024151A1 (en) 1994-10-27
NO954091L (en) 1995-12-13
JPH08508743A (en) 1996-09-17
AU688316B2 (en) 1998-03-12
HUT74091A (en) 1996-11-28
HU9502977D0 (en) 1995-12-28
CN1120845A (en) 1996-04-17
EP0694040A1 (en) 1996-01-31
PL311083A1 (en) 1996-02-05
FI954852A (en) 1995-10-12

Similar Documents

Publication Publication Date Title
NO954090D0 (en) 1.5 Benzodiazepine derivatives with CCK antagonistic or agonistic activity
NL350016I1 (en) 3-Aryl-4-hydroxy-delta # 3-dihydrofuranone and 3-aryl-4-hydroxy-delta # 3-dihydrothiophenone derivatives.
DE69404855T2 (en) FOLDABLE WING
ITMI931518A0 (en) HEPARIN DERIVATIVES WITH ANTI-METASTIC ACTIVITY
FI932074A (en) Anordning Foer att i en bearbetningsanlaeggning transportera and positionera foerdelaktigt laongstraeckta arbetsstycken, saerskilt arbetsstycken av trae
FI952063A (en) Penemes with substituted 6-methylene, and intermediates
DE59009878D1 (en) Dye mixtures and their use.
MX9203459A (en) NEW DERIVATIVES OF 2'-HALOMETILIDENO, 2'-ETENILIDENO AND 2'-ETINILCITIDINA, URIDINA AND GUANOSINA.
DE69114342T2 (en) Fluorine-containing diaminobenzene derivatives and their use.
FI954852A0 (en) 1,5-bentzodiazepine derivatives with CCK and / or gastrin antagonistic activity
DE68918215D1 (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives.
FI955679A (en) Piperidine derivatives, preparation and use thereof
FI933376A0 (en) 4-AMINO-3-ACYLKINOLINDERIVATER AND DERASE ANVAENDNING SOM INHIBITORER AVMAGSYRASEKRETION
ITTO920114A1 (en) BIS-TETRAZOLIC DERIVATIVES FOR ANTIALLERGIC AND CITOPROTECTIVE ACTIVITIES
DE69203699D1 (en) Arylindazole derivatives and their use.
NO903229L (en) SUBSTITUTED ISOXSAZOL AND ISOTIAZOL DERIVATIVES.
FI892281A0 (en) 3-PYRROLIDINYLTIO-1-AZABICYCLO / 3.2.0 / HEPT-2-EN-2-CARBOXYLSYRADERIVES AND FRAMSTAELLNING.
FI931624A (en) ACETYLENER DISUBSTITUES MED EN HETEROAROMATISK GRUPP OCH EN 2-SUBSTITUERAD KROMANYL, TIOKROMANYL ELLER 1,2,3,4-TETRAHYDROKINOLINYGRUPP MED RETINOID-LIK ACTIVITY
DE59008017D1 (en) Dye mixtures and their use.
DE59009237D1 (en) Dye mixtures and their use.
DE59007243D1 (en) Dye mixtures and their use.
FI962988A (en) 1,1,1-trifluoro-2-propylene compounds and their preparation
ATE104289T1 (en) AMINOETHYLTHIAZOLE AND AMINOETHYLOXAZOLE DERIVATIVES.
FI932374A0 (en) Saett och anordning Foer att foerse en plastfolie ellan likanande med beslag
FI932581A0 (en) Foerfarande ocfskonstruktion Foer effektiv kylning av ugnens botten oceggar and aktttagande av vaermeutvidgning